美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CAR-T

1,585.10

+12.610.80%

涨家数：1

跌家数：- -

平家数：1

市盈率：- -

高：1,598.09

开：1,574.21

低：1,573.78

收：1,572.49

成交量：1,042.41万

成交额：12.95亿

市值：4,119.67亿

流通市值：3,992.43亿

数据加载中...

总览新闻资讯

迈科康生物筹备A股上市：董事长陈德祥是海归博士，曾任职于辉瑞、诺华

消息称白宫即将宣布与诺华、罗氏达成药品定价协议

消息人士称，艾伯维和其他几家制药公司接近与特朗普达成最惠国待遇协议

诺华和罗氏据悉接近与美国政府就药品价格达成协议

环球市场播报

分析师称基因疗法带来成本冲击

环球市场播报

吉利德公司的试验性艾滋病治疗药物在后期试验中达到主要目标

吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点

中国同辐(01763.HK)与诺华公司合作推广前列腺癌治疗药物派威妥®

中国同辐(01763)附属原子高科与诺华公司签署商业合作协议

生存数据不佳，Arcus 放弃晚期癌症试验

吉利德公司和 Arcus 公司放弃抗癌药物组合的后期试验

吉利德科学 - 中期分析显示，Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期

美国研究综述-摩根大通、百事可乐、辉瑞制药

美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点

诺华制药(NVS.US)17亿美元押注英国AI药企布局过敏性疾病新靶点

吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4578/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1585.0984,"timestamp":1766005199999,"preClose":1572.4861,"halted":0,"volume":10424131,"delay":0,"changeRate":0.008021,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":12.612305,"latestTime":"12-17 16:00:00 EST","open":1574.2073,"high":1598.0863,"low":1573.779,"amount":1295052323.619431,"amplitude":0.015458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.193916,"peRate":18.130614,"turnoverRate":0.003382,"increases":1,"decrements":0,"flats":1,"marketCap":411967143936,"floatMarketCap":399242903552},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1598.0863,"amplitude":0.015458,"preClose":1572.4861,"low":1573.779,"pbRate":"6.193916","latestPrice":1585.0984,"volume":10424131,"delay":0,"open":1574.2073,"prevYearClose":1164.883,"prevWeekClose":1561.935,"prevMonthClose":1571.367,"prevQuarterClose":1484.4005,"fiveDayClose":1556.4049,"twentyDayClose":1560.2986,"sixtyDayClose":1460.5715,"secType":"PLATE","market":"US","turnoverRate":0.003382,"peRate":18.130614,"marketCap":411967143936,"floatMarketCap":399242903552,"timestamp":1766005199999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":0,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592234399","title":"迈科康生物筹备A股上市：董事长陈德祥是海归博士，曾任职于辉瑞、诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2592234399","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592234399?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 09:19","pubTimestamp":1766020762,"startTime":"0","endTime":"0","summary":"迈科康生物针对传染性、过敏性疾病及肿瘤领域布局了多样化的产品研发管线，包括多个针对重大传染病的预防性疫苗，以及HPV感染、过敏性疾病、癌症等领域的治疗性疫苗，目前已有3项进入临床试验阶段。目前，迈科康生物控股股东为成都谦鼎企业管理咨询有限公司，直接持有公司 22.09%股权。官网显示，迈科康生物董事长，总经理为陈德祥，首席科学家为Mark R. Alderson。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218091931a459023b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218091931a459023b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","LU0306806265.USD","LU0122379950.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU0985481810.HKD","LU0225771236.USD","LU0321505868.SGD","BK4007","BK4585","SG9999013999.USD","IE00BJT1NW94.SGD","BK4592","SG9999002232.USD","LU0456855351.SGD","BK4588","LU0211331839.USD","BK4532","IE00B2B36J28.USD","PFE","BK4550","LU1066051498.USD","300463","LU1023059063.AUD","SG9999002224.SGD","IE00BBT3K403.USD","BK4578","LU0868494617.USD","BK4568","IE00B19Z3B42.SGD","LU0320765489.SGD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","BK4534","LU0321505439.SGD","LU0208291251.USD","LU0306807586.USD","SG9999001176.USD","LU0058720904.USD","LU1883839398.USD","LU1894683348.USD","SG9999011175.SGD","IE0002141913.USD","IE0002270589.USD","BK4533","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1894683264.USD","NVS","SG9999001176.SGD","SG9999003800.SGD","IE00BLSP4239.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU0170899867.USD","LU1066053197.SGD","BK4581","IE00BLSP4452.SGD","BK4599","LU0225284248.USD"],"gpt_icon":0},{"id":"2592462199","title":"消息称白宫即将宣布与诺华、罗氏达成药品定价协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2592462199","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592462199?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 06:27","pubTimestamp":1766010475,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4578","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0070302665.USD","LU0320765489.SGD","NVS","IE00BJJMRZ35.SGD","BK4588","LU0211331839.USD","BK4532","IE00B2B36J28.USD","BK4007","LU0208291251.USD","BK4585","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2592943841","title":"消息人士称，艾伯维和其他几家制药公司接近与特朗普达成最惠国待遇协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2592943841","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592943841?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 04:51","pubTimestamp":1766004690,"startTime":"0","endTime":"0","summary":"更新 3-消息人士称，艾伯维和其他几家制药公司接近与特朗普达成最惠国待遇协议将标题改为USA-TRUMP/DRUGPRICING；重新编排以更改来源；添加关于来源的艾伯维公司以及其他公司的详细信息，第1、2、6、7段；添加潜在的CMS示范项目的详细信息，第5段；分析师评论，第4段Deena Beasley/Jarrett Renshaw/Michael Erman. 其中几位消息人士说，与大约五家公司达成的协议预计将在周五宣布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL4S3XN1PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ99366536.SGD","LU0432979614.USD","BK4585","LU0128525689.USD","LU0784383803.USD","LU1880407215.USD","LU2129689514.USD","SG9999014567.USD","LU0096364046.USD","SG9999014906.USD","LU2125154935.USD","LU1032955483.USD","LU2106854487.HKD","IE00BFSS8Q28.SGD","IE0002270589.USD","LU2237443382.USD","SG9999002224.SGD","LU0070302665.USD","LU0820561818.USD","LU2491050154.USD","LU0960981461.USD","LU1974910355.USD","LU2362540622.SGD","SG9999017495.SGD","LU1670710588.SGD","LU0784385170.HKD","LU0354030438.USD","IE0034235188.USD","IE00BBT3K403.USD","LU1868836591.USD","LU1551013425.SGD","LU2168564149.EUR","LU2471134952.CNY","LU0965508806.USD","LU1069344957.HKD","LU1069347547.HKD","BK4588","LU0256863902.USD","LU1035777561.USD","LU0029864427.USD","LU2750360641.GBP","IE00B42XCP33.USD","LU0006306889.USD","LU0237698245.USD","LU0971552673.USD","LU0208291251.USD","LU0738911758.USD","LU1941712264.USD","LU1093756168.USD","LU0980610538.SGD","LU0052756011.USD","IE00B1BXHZ80.USD","LU1430594728.SGD","LU1481599808.USD","LU2023250843.SGD","LU1116320737.USD","BK4139","LU0786609619.USD","LU1571399168.USD","LU0320765059.SGD","LU0238689110.USD","LU1066053197.SGD","LU1244550577.SGD","LU2361044865.SGD","LU1232071149.USD","LU0321505439.SGD","LU0640476718.USD","LU1868836914.USD","LU1989771016.USD","LU1093756325.SGD","LU1868837300.USD","LU0094547139.USD","LU1037948541.HKD","LU0306806265.USD","IE00BWXC8680.SGD","LU0889566641.SGD","LU1674673691.USD","LU0943347566.SGD","IE00BQJZX424.USD","IE00B7KXQ091.USD","LU0234572021.USD","LU1934455863.HKD","LU1720051017.SGD","LU2125154778.USD","LU0545039389.USD","LU0345769128.USD","LU0265550946.USD","LU1116320901.HKD","LU1670711123.USD","IE000M9KFDE8.USD","LU0211328371.USD","LU1623119135.USD","LU0823434583.USD","LU1804176565.USD","BK4568","LU1196500208.SGD","LU2089984988.USD","LU0912757837.SGD","LU1868836757.USD","SG9999015358.SGD","LU0949170772.SGD","LU1244550494.USD","BK4516","LU2023250504.SGD","LU0353189763.USD","IE00BGHQF631.EUR","LU0077335932.USD","LU0683600562.USD","BK4532","ABBV","LU0211326839.USD","IE00BJJMRX11.SGD","LU2091194634.USD","LU0061475181.USD","LU0640478417.SGD","LU1732799900.SGD","LU1935042991.SGD","LU0920783379.SGD","LU1064927863.SGD","LU1119994496.HKD","IE00BFXG1179.USD","LU0417517546.SGD","IE00B775H168.HKD","LU1244550221.USD","LU0957799991.USD","LU0889565080.SGD","BK4578","BK4592","LU1814569148.SGD","IE0034235071.USD","LU0575583348.USD","SGXZ31699556.SGD","IE00BFSS7M15.SGD","LU0225284248.USD","LU0661504455.SGD","LU1015430645.USD","LU0861579265.USD","LU2539964713.USD","LU1883839398.USD","LU0353189680.USD","LU1778281490.HKD","LU0321505868.SGD","LU2168564222.USD","LU2242646821.SGD","LU2087625088.SGD","IE00BN8TJ469.HKD","LU0109391861.USD","LU0965509283.SGD","LU0689626769.HKD","LU0784385840.USD","LU1929549753.HKD","LU0757432116.USD","LU0211326755.USD","LU2471134523.USD","LU1261432733.SGD","03165","LU1914381329.SGD","LU0320765489.SGD","LU1221951046.USD","IE00BJT1NW94.SGD","LU0795875169.SGD","LU0708994859.HKD","SGXZ51526630.SGD","LU1941712348.USD","IE0034235303.USD","LU1983299246.USD","LU2361045086.USD","LU2746668461.USD","LU0316494557.USD","LU1366192091.USD","BK4007","SG9999014559.SGD","LU1037948897.HKD","LU0965509101.SGD","LU1712237335.SGD","LU1267930490.SGD","LU0109394709.USD","LU1019634622.SGD","LU1162221912.USD","LU0011850046.USD","LU0971552830.HKD","LU0976567544.SGD","LU1988902786.USD","LU2461242641.AUD","LU0345770308.USD","LU2089283258.USD","LU1720051108.HKD","BK5011","LU2417539215.USD","LU1880407132.USD","SG9999018865.SGD","LU0306807586.USD","LU0882574139.USD","LU1400636491.USD","LU2602419157.SGD","LU2552382058.USD","LU1548497426.USD","IE00B2B36J28.USD","LU1066051811.HKD","LU1699723380.USD","IE00B4JS1V06.HKD","LU0128525929.USD","LU0689472784.USD","SGXZ81514606.USD","LU0070217475.USD","LU0225771236.USD","LU2114397693.USD","LU2237438978.USD","LU2237443978.SGD","LU1074936037.SGD","LU1280957306.USD","LU0969580561.USD","SG9999014542.SGD","LU0310800965.SGD","LU0827474353.SGD","LU2361044949.HKD","LU2129689605.HKD","IE00BDGV0183.EUR","LU0985481810.HKD","LU2430703095.HKD","LU0266013472.USD","LU0823434740.USD","LU2133065610.SGD","BK4550","IE00B3T34201.USD","LU0795875086.SGD","LU1989772840.SGD","LU0920840948.USD","LU0345769631.USD","LU0171293334.USD","LU0053666078.USD","IE00BVYPNW00.USD","LU2168563687.JPY","LU2552382215.SGD","LU0499090636.EUR","LU0256863811.USD","LU0949170426.SGD","LU0787776722.HKD","LU2089284900.SGD","SG9999014880.SGD","LU2456880835.USD","LU1003077747.HKD","LU0047473722.EUR","LU1481600234.SGD","SG9999003800.SGD","LU1585245621.USD","IE00B1XK9C88.USD","LU0964806797.USD","LU0267386448.USD","LU2237443465.HKD","LU2592432038.USD","SG9999001176.USD","IE00BFTCPJ56.SGD","LU2471134879.HKD","LU1035775433.USD","LU1732800096.USD","LU0385154629.USD","IE00BKPKM643.USD","LU1670710661.SGD","LU0471298694.HKD","LU0997586432.USD","SG9999014575.USD","LU0198837287.USD","LU0972486137.USD","LU0354030511.USD","LU0553294199.USD","LU0823416689.USD","LU0708995401.HKD","LU1267930573.SGD","LU0170899867.USD","LU1023059063.AUD","LU1104425308.USD","LU2293690249.USD","LU2129689431.USD","IE00BKDWB100.SGD","IE00BSNM7G36.USD","LU1670756490.USD","LU1645745479.HKD","LU0985320562.USD","LU1301847155.USD","LU0557290698.USD","LU0265550359.USD","LU2087621335.USD","LU2362541273.HKD","LU1309081286.SGD","SGXZ57979304.SGD","LU2063271972.USD","LU2108987350.USD","LU1989772923.USD","IE0005OL40V9.USD","LU1003076772.USD","LU0130102774.USD","LU0124676726.USD","LU0058720904.USD","SG9999015986.USD","IE00BVYPNV92.GBP","LU2023251221.USD","LU2505996681.GBP","LU1201861249.SGD","LU2168564495.EUR","IE00B7SZLL34.SGD","SG9999013999.USD","LU0526926950.USD","LU1670711040.USD","LU1066051225.USD","SG9999001176.SGD","LU0345770993.USD","LU1035773651.USD","LU0889565916.HKD","LU0466842654.USD","LU1506573853.SGD","IE00BWDBJ516.SGD","LU1267930227.SGD","SG9999015978.USD","LU2211815571.USD","LU0471298777.SGD","LU0158827948.USD","LU2237443549.SGD","BK4583","LU0079474960.USD","LU0234570918.USD","IE00BLSP4239.USD","LU0820561909.HKD","LU0868494617.USD","LU1061106388.HKD","LU2462157665.USD","LU1868837136.USD","SG9999001440.SGD","SG9999018857.SGD","LU0857590862.USD","LU0882574055.USD","LU2746668974.SGD","LU2362541513.USD","LU1098665638.USD","IE00BJLML261.HKD","LU1051770623.HKD","LU1894683264.USD","LU1934455194.USD","LU1496350502.SGD","LU1046248800.SGD","LU0203347892.USD","LU2237443622.USD","LU0965509010.AUD","SG9999014914.USD","LU0047473722.SGD","LU2279689827.SGD","LU1059921491.USD","LU0310799852.SGD","LU0106261372.USD","LU0161305163.EUR","LU1202635105.USD","LU1400636574.HKD","LU0456855351.SGD","BK4504","LU0545562505.USD","LU1302929846.USD","LU2491050071.SGD","SG9999015952.SGD","LU1127390331.HKD","LU1170363599.USD","LU2236285917.USD","LU2293690082.USD","IE00BZ1G4Q59.USD","LU0792757196.USD","LU1839511570.USD","IE00BK4W5L77.USD","LU1032466523.USD","LU0130517989.USD","LU0098860793.USD","LU1400636657.SGD","LU2471134796.USD","LU1674673428.USD","LU0203345920.USD","LU2265009873.SGD","LU1057294990.SGD","LU2430703251.USD","LU0109981661.USD","LU0114720955.EUR","LU1228905540.USD","LU1551013342.USD","LU0203201768.USD","LU0496365809.HKD","LU1267930730.SGD","LU1084165304.USD","LU0345777147.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2750360997.AUD","LU1153584641.USD","LU2237443895.HKD","LU2430703178.SGD","LU2360032135.SGD","LU1291159041.SGD","LU1066051498.USD","IE0004445015.USD","IE00B19Z3581.USD","LU2168564065.EUR","BK4599","LU0672654240.SGD","LU2491049909.HKD","LU1487256676.USD","LU1917777945.USD","LU0211331839.USD","LU2552382132.HKD","LU2360106947.USD","LU1078025761.USD","IE0002141913.USD","IE00B3PB1722.GBP","LU0963555726.SGD","LU0784384876.USD","LU2264538146.SGD","IE00BKVL7J92.USD","LU0648001328.SGD","SG9999015945.SGD","SG9999015341.SGD","BK4533","BK4566","LU2468319806.SGD","SG9999011175.SGD","LU1718418525.SGD","LU2242652126.USD","IE00B19Z3B42.SGD","LU2505996509.AUD","IE00BN29S564.USD","SG9999002232.USD","LU0320765992.SGD","LU0203202063.USD","LU0211327993.USD","LU0345777659.USD","LU0320765646.SGD","BK4581","SG9999014898.SGD","IE00BJJMRY28.SGD","LU2112291526.USD","IE0004445239.USD","LU0122379950.USD","LU0823399737.USD","IE00BLSP4452.SGD","LU0477156953.USD","LU1019632923.USD","BK4534","LU1267930813.SGD","BK4559","LU1323610961.USD","LU2357305700.SGD","LU0323591593.USD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU2324357040.USD","LU0097036916.USD","LU1064131342.USD","IE0009355771.USD","LU1153585028.USD","IE00B4R5TH58.HKD","LU1934455277.USD","LU1228905037.USD","LU2347655156.SGD","LU1894683348.USD","LU0310800379.SGD","LU1496350171.SGD","IE00BKPKM429.USD","LU1221951129.SGD"],"gpt_icon":0},{"id":"2592194948","title":"诺华和罗氏据悉接近与美国政府就药品价格达成协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2592194948","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592194948?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 04:24","pubTimestamp":1766003040,"startTime":"0","endTime":"0","summary":"根据知情人士透露，白宫即将宣布与制药巨头诺华和罗氏控股达成药品定价协议，最早可能于周五宣布，这将在关税僵局后进一步缓解美国与瑞士的贸易紧张局势。辉瑞、阿斯利康等公司近月来也与特朗普政府达成了协议，同意在某些情况下降低价格，以换取关税减免。　　特朗普今年夏天致信17家制药公司，要求其为美国政府保险项目削减成本，同意通过特朗普品牌的直销平台销售药品，并保证未来推出的药品价格与海外价格相当。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2025-12-18/doc-inhceazv7078642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4532","IE0009355771.USD","IE00BJJMRZ35.SGD","NVS","BK4578","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4007","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4585","LU0211331839.USD","IE00BFTCPJ56.SGD","BK4588","IE0002141913.USD","LU0070302665.USD","LU0208291251.USD"],"gpt_icon":0},{"id":"2591640006","title":"分析师称基因疗法带来成本冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2591640006","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591640006?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 23:46","pubTimestamp":1765813560,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics（SRPT）的Elevidys和诺华（NVS）的Zolgensma展现了突破性疗效，但分析师指出，其数亿美元的标价也随着研发管线扩张，给雇主和保险公司带来可负担性挑战。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-15/doc-inhaxefx1673407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SINA","SRPT","BK4007","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4588","IE00B4R5TH58.HKD","BK4139","BK4532","LU0070302665.USD","LU0211331839.USD","BK4585","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4578","IE0009355771.USD","LU0320765489.SGD","IE0002141913.USD","NVS"],"gpt_icon":0},{"id":"2591641948","title":"吉利德公司的试验性艾滋病治疗药物在后期试验中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641948","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641948?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 21:34","pubTimestamp":1765805654,"startTime":"0","endTime":"0","summary":"吉利德公司的试验性艾滋病治疗药物在后期试验中达到主要目标路透12月15日 - 吉利德科学公司（Gilead Sciences GILD.O）周一表示，其试验性艾滋病治疗在一项后期试验中达到了主要目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL4T3XL0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00B19Z3581.USD","SG9999015978.USD","GILD","LU0320765992.SGD","BK4550","LU0823416689.USD","LU1778281490.HKD","LU2087621335.USD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1571399168.USD","LU0114720955.EUR","BK4139","LU0882574055.USD","LU0889565916.HKD","LU1430594728.SGD","LU0058720904.USD","BK4578","SG9999015945.SGD","LU0109394709.USD","BK4585","BK4588","IE00B19Z3B42.SGD","SG9999015952.SGD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","BK4566","LU1674673691.USD","LU2089984988.USD","BK4583","BK4532","LU1585245621.USD","IE0002270589.USD","LU2324357040.USD","BK4568","LU1066051498.USD","SG9999015986.USD","IE00BSNM7G36.USD","LU0289739699.SGD","IE00BKVL7J92.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"1132993871","title":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1132993871","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132993871?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 21:32","pubTimestamp":1765805534,"startTime":"0","endTime":"0","summary":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU0234570918.USD","IE00BKVL7J92.USD","BK4550","LU0882574055.USD","LU0823416689.USD","LU1674673691.USD","LU2089984988.USD","BK4139","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU2087621335.USD","LU1430594728.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1674673428.USD","LU2468319806.SGD","LU1066053197.SGD","BK4566","BK4532","LU0114720955.EUR","SG9999015978.USD","IE00B3T34201.USD","BK4583","BK4588","LU1585245621.USD","LU0109394709.USD","IE0002270589.USD","SG9999015986.USD","IE00B19Z3581.USD","LU1839511570.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","GILD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4578","LU0320765992.SGD","LU0889565916.HKD","LU1066051498.USD","LU2324357040.USD","LU1571399168.USD","BK4585"],"gpt_icon":0},{"id":"2591641243","title":"中国同辐(01763.HK)与诺华公司合作 推广前列腺癌治疗药物派威妥®","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641243","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591641243?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 21:16","pubTimestamp":1765804604,"startTime":"0","endTime":"0","summary":"格隆汇12月15日丨中国同辐宣布，公司附属公司原子高科股份有限公司与诺华医药科技(浙江)有限公司正式签署派威妥商业合作协议。此次签约开启了双方在创新核药产品派威妥方面的战略合作，原子高科将凭藉在放射性药物领域的多年合规运营经验，与诺华公司强强联合，为医疗机构和患者提供定制化的派威妥产品供应与解决方案，以惠及更多的患者。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/12/15211654701937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1222","IE0002141913.USD","BK4578","LU0211331839.USD","NVS","BK4585","BK4588","BK4007","01763","LU0208291251.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4532","IE00B2B36J28.USD","LU0070302665.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2591649704","title":"中国同辐(01763)附属原子高科与诺华公司签署商业合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649704","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591649704?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 21:15","pubTimestamp":1765804518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司附属公司原子高科股份有限公司(原子高科)与诺华医药科技(浙江)有限公司(诺华公司)正式签署派威妥®(镥[177Lu]特昔维匹肽注射液)商业合作协议(商业合作协议)。派威妥® 是国内首个且目前唯一获批的靶向PSMA的放射配体疗法药物，主要用于治疗晚期前列腺癌，未来将为患者提供延长生命并改善生活质量的全新核药治疗方案。此次签约开启了双方在创新核药产品派威妥®方面的战略合作，原子高科将凭藉在放射性药物领域的多年合规运营经验，与诺华公司强强联合，为医疗机构和患者提供定制化的派威妥®产品供应与解决方案，以惠及更多的患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","BK4585","NVS","IE0009355771.USD","BK4588","LU0211331839.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4532","BK4007","IE0002141913.USD","BK1222","BK4578","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0070302665.USD","01763"],"gpt_icon":0},{"id":"2590232501","title":"生存数据不佳，Arcus 放弃晚期癌症试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2590232501","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590232501?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 21:41","pubTimestamp":1765546916,"startTime":"0","endTime":"0","summary":"更新版 3-生存数据不佳，Arcus 放弃晚期癌症试验更新股份，在第 9 段增加背景，在第 10 段增加分析师评论Kamal  Choudhury路透12月12日 - Arcus Biosciences RCUS.N周五表示，由于未能提高晚期胃癌和食管癌患者的生存率，该公司将停止 一项晚期研究，停止 对晚期胃癌和食管癌患者进行试验性抗癌药物组合的测试。消息传出后，Arcus公司股价在早盘交易中 下跌了8% ，而吉利德公司的股价则略有下跌。Arcus表示，一项测试相同组合方案的相关中期研究也将终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","SG9999001176.USD","LU2242652126.USD","LU2242646821.SGD","LU0861579265.USD","LU1066051811.HKD","LU1037948897.HKD","LU2360032135.SGD","LU0289739699.SGD","LU2324357040.USD","RCUS","LU0130517989.USD","SG9999015986.USD","BK4578","BK0239","BMY","GILD","LU1699723380.USD","SG9999014559.SGD","IE00BJT1NW94.SGD","BK4516","SG9999002224.SGD","LU0980610538.SGD","LU1069347547.HKD","LU1929549753.HKD","LU1162221912.USD","SG9999001176.SGD","LU0965509283.SGD","LU2461242641.AUD","LU0208291251.USD","LU2125154935.USD","LU1670710661.SGD","SG9999001440.SGD","LU0225771236.USD","LU1201861249.SGD","MRK","LU0267386448.USD","LU0320765489.SGD","LU0203345920.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU0889565916.HKD","LU2087621335.USD","LU1116320901.HKD","LU1934455863.HKD","688235","LU2023250504.SGD","IE00B4R5TH58.HKD","SG9999015945.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2590501504","title":"吉利德公司和 Arcus 公司放弃抗癌药物组合的后期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2590501504","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590501504?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 21:30","pubTimestamp":1765546228,"startTime":"0","endTime":"0","summary":"吉利德公司和 Arcus 公司放弃抗癌药物组合的后期试验路透12月12日 - 吉利德科学公司（Gilead Sciences GILD.O）和Arcus生物科学公司（Arcus Biosciences RCUS.N）周五表示，他们将停止一项晚期研究，该研究将对晚期胃癌和食管癌患者进行试验性抗癌药物联合治疗，因为该研究未能显示出生存获益。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0882574055.USD","BK4566","LU2089984988.USD","LU1674673691.USD","LU0114720955.EUR","LU1066053197.SGD","GILD","BK4583","IE00B7SZLL34.SGD","LU0289739699.SGD","RCUS","SG9999015986.USD","BK4578","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4588","LU1839511570.USD","SG9999015952.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015978.USD","BK4532","IE00B19Z3B42.SGD","BK4550","LU1066051498.USD","LU1778281490.HKD","LU0320765992.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","LU0823416689.USD","BK4585","LU0234570918.USD","LU1571399168.USD","LU2087621335.USD","LU1585245621.USD","BK4139","LU2324357040.USD","SG9999015945.SGD","IE0002270589.USD","BK4568","IE00BSNM7G36.USD","LU0058720904.USD","IE00BKVL7J92.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"1123601921","title":"吉利德科学 - 中期分析显示，Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123601921","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123601921?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 21:29","pubTimestamp":1765546157,"startTime":"0","endTime":"0","summary":"吉利德科学 - 中期分析显示，Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00BKVL7J92.USD","LU1674673428.USD","SG9999015978.USD","BK4583","BK4566","LU1066053197.SGD","SG9999015952.SGD","GILD","BK4532","LU2087621335.USD","LU1778281490.HKD","LU0114720955.EUR","LU0234570918.USD","BK4585","BK4578","LU1585245621.USD","LU1674673691.USD","BK4139","LU2089984988.USD","BK4550","IE00B19Z3581.USD","LU1571399168.USD","LU1839511570.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU0289739699.SGD","LU0058720904.USD","IE0002270589.USD","BK4568","LU2324357040.USD","SG9999015945.SGD","IE00BSNM7G36.USD","SG9999015986.USD","LU0889565916.HKD","LU1066051498.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU0882574055.USD","BK4588","LU2468319806.SGD"],"gpt_icon":0},{"id":"2590305440","title":"美国研究综述-摩根大通、百事可乐、辉瑞制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2590305440","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590305440?lang=zh_cn&edition=fundamental","pubTime":"2025-12-10 14:43","pubTimestamp":1765349017,"startTime":"0","endTime":"0","summary":"美国研究综述-摩根大通、百事可乐、辉瑞制药路透12月10日 - 华尔街证券分析师周三调整了对摩根大通、百事可乐和辉瑞等多家美国上市公司的评级和目标价。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4T3XG0E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775H168.HKD","LU2023250504.SGD","SG9999015978.USD","LU0985320562.USD","LU1064131342.USD","LU0432979614.USD","GB00BDT5M118.USD","LU1623119135.USD","LU1721429402.USD","LU1585245621.USD","BK4207","LU1366192091.USD","IE00BK4W5M84.HKD","LU1868837136.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","LU1244550494.USD","BK4200","LU0029864427.USD","LU2111349929.HKD","LU0345774391.USD","LU0211326839.USD","LU0368265764.SGD","BK4592","BK4583","BK4104","LU2505996509.AUD","LU0320765489.SGD","LU0661504455.SGD","LU0306807586.USD","IE00BWXC8680.SGD","LU0971096721.USD","SG9999014559.SGD","LU0788108826.HKD","LU1988902786.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU1057294990.SGD","LU1917777945.USD","SG9999014575.USD","LU0170899867.USD","IE0009355771.USD","LU0471298777.SGD","IE00BK4W5L77.USD","IE00B775SV38.USD","LU1267930813.SGD","LU1883866441.USD","LU0823434740.USD","LU0354030438.USD","LU2089984988.USD","LU2471134796.USD","LU0203202063.USD","LU1989772923.USD","LU2125910336.SGD","LU0354030511.USD","SG9999014914.USD","IE0002270589.USD","SG9999002224.SGD","BK4588","LU2361044865.SGD","LU1032955483.USD","BK4177","LU0094547139.USD","LU2028103732.USD","SG9999015986.USD","LU0496365809.HKD","BK4516","LU1868836914.USD","LU0070217475.USD","LU1496350502.SGD","LU0267386448.USD","LU2242652126.USD","LU0211331839.USD","BK4578","LU0097036916.USD","BK4581","IE00BHPRN162.USD","LU1116320737.USD","LU1989763005.USD","IE00BLSP4452.SGD","BK4522","BK4212","IE00B3PB1722.GBP","LU2517655291.USD","LU2242649171.HKD","LU1236620750.USD","LU1732799900.SGD","BK4567","LU0058720904.USD","LU1261432733.SGD","LU0061475181.USD","LU0868494708.USD","LU2471134952.CNY","IE0034235188.USD","BK4534","LU2360032135.SGD","LU1894683264.USD","LU1914381329.SGD","LU1363072403.SGD","SG9999014880.SGD","BK4173","LU1145028129.USD","IE00B3CCJ963.GBP","LU0203345920.USD","LU0128525929.USD","IE00B19Z9Z06.USD","IE0034235295.USD","LU0795875169.SGD","LU0820561818.USD","IE00BJTD4V19.USD","LU2381873111.SGD","LU0203201768.USD","LU0211327993.USD","LU0256863902.USD","LU0289739699.SGD","LU2750360997.AUD","LU0225771236.USD","BK4209","LU1244550577.SGD","IE00BKDWB100.SGD","LU0234570918.USD","LU1548497426.USD","LU0345780521.USD","IE00B4JS1V06.HKD","LU1670710661.SGD","LU0708994859.HKD","LU2517655028.SGD","LU2462157665.USD","LU2462611646.USD","LU1127390331.HKD","BK4559","LU0433182093.SGD","LU1323610961.USD","LU0368265418.SGD","LU0912757837.SGD","LU1430597077.USD","IE00B1BXHZ80.USD","LU2491050154.USD","LU1582987597.SGD","LU0672654240.SGD","BK4570","LU0345770993.USD","LU0353189680.USD","LU1923621640.USD","SG9999018857.SGD","LU1670711040.USD","LU2237443549.SGD","LU1582986359.USD","SG9999001440.SGD","LU2552382215.SGD","LU0203347892.USD","LU1674673428.USD","LU0786609619.USD","LU2361044949.HKD","LU0122379950.USD","LU0225284248.USD","LU2308191902.HKD","SGXZ31699556.SGD","LU0098860793.USD","LU0985489474.SGD","LU1883839398.USD","BK4201","LU1934455277.USD","LU0345769128.USD","LU1670710588.SGD","LU1718418525.SGD","JPM","LU0820561909.HKD","LU1223083913.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00BDCRKT87.USD","LU0949170772.SGD","LU2471134879.HKD","LU2237443465.HKD","IE00BVYPNV92.GBP","LU2750360641.GBP","LU1430594728.SGD","IE00BBT3K403.USD","LU0215105999.USD","LU1069344957.HKD","LU1551013425.SGD","LU2491049909.HKD","LU1941712348.USD","LU1267930490.SGD","BK4532","IE00B19Z9505.USD","LU0738911758.USD","LU0823434583.USD","LU2063271972.USD","SG9999001176.SGD","SG9999017495.SGD","LU0878866978.SGD","LU1712237335.SGD","LU0265550359.USD","IE00B3S45H60.SGD","IE00BVYPNW00.USD","SG9999014567.USD","LU2089283258.USD","LU0498741890.SGD","LU0498741114.HKD","LU0792757196.USD","LU0320765059.SGD","LU0266512473.USD","SGXZ57979304.SGD","LU0122376428.USD","LU1119994496.HKD","LU1894683348.USD","LU2229751404.USD","IE00BJT1NW94.SGD","IE00B7SZLL34.SGD","LU0612318971.USD","LU1506573853.SGD","LU2552382058.USD","LU0820562030.AUD","LU0321505439.SGD","LU0256863811.USD","BK4139","LU1221951129.SGD","LU2108987350.USD","LU2213496289.HKD","LU0683600562.USD","LU0385154629.USD","LU0654597011.USD","LU2168564495.EUR","LU0612318385.USD","LU1116320901.HKD","BK4550","LU2417539215.USD","LU1571399168.USD","LU0109394709.USD","BK4166","LU1804176565.USD","LU0320765646.SGD","LU0266512127.USD","LU1551013342.USD","BK4568","BK4023","LU0211326755.USD","LU1093756325.SGD","LU2592432038.USD","LU1868837300.USD","LU0882574139.USD","LU1066053197.SGD","SG9999001176.USD","LU1934455194.USD","LU1974910355.USD","SG9999014542.SGD","LU0300736062.USD","LU2264538146.SGD","LU2357305700.SGD","LU0823416689.USD","LU0942090050.USD","LU2237443382.USD","IE00B42XCP33.USD","LU1732800096.USD","LU0976567544.SGD","LU0345769631.USD","LU2468319806.SGD","LU1037948897.HKD","LU2380233275.USD","IE00B3T34201.USD","IE00BJJMRY28.SGD","LU1668664300.SGD","LU2461242641.AUD","IE00BLSP4239.USD","LU0466842654.USD","LU0640476718.USD","LU0208291251.USD","LU0545039389.USD","LU1150488218.USD","LU1778281490.HKD","LU2552382132.HKD","IE0034235303.USD","LU1236620834.HKD","LU1934455863.HKD","LU2237443622.USD","BK4585","LU0321505868.SGD","BK4083","LU0300736492.USD","LU0266013472.USD","LU1489326972.SGD","LU0553294199.USD","IE00BFSS8Q28.SGD","LU2746668974.SGD","LU0861579265.USD","PEP","LU2347655156.SGD","LU0889566641.SGD","LU0055631609.USD","LU1066051498.USD","LU2602419157.SGD","BK4539","SG9999015952.SGD","LU2168564149.EUR","LU0496367417.USD","LU2168564065.EUR","IE0005OL40V9.USD","IE00BN29S564.USD","BK4599","LU0198837287.USD","LU0708995401.HKD","LU0471298694.HKD","LU0323591593.USD","LU1032466523.USD","SG9999013999.USD","LU1814569148.SGD","LU0353189763.USD","LU0278409577.USD","LU2756315664.SGD","LU1150488135.SGD","LU1061106388.HKD","LU0965508806.USD","LU2237438978.USD","SGXZ51526630.SGD","LU0456854461.SGD","LU1496350171.SGD","LU2112291526.USD","LU1721429741.USD","IE00BFXG1179.USD","LU2133065610.SGD","LU2023250330.USD","LU2362540622.SGD","LU2430703178.SGD","LU2125910179.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU1720051017.SGD","PFE","SGXZ81514606.USD","LU0345770308.USD","LU0985481810.HKD","IE00BSNM7G36.USD","LU1035775433.USD","LU0345774631.USD","LU0345780950.USD","IE00B19Z9P08.USD","LU0234572021.USD","LU1074936037.SGD","IE00BJLML261.HKD","SG9999015945.SGD","SG9999002521.SGD","LU0943347566.SGD","LU1232071149.USD","LU1223082196.USD","LU0096364046.USD","LU0251132253.USD","LU0006306889.USD","LU0310800379.SGD","LU2517655374.HKD","SG9999014906.USD","LU0107464264.USD","LU0345780281.USD","LU2360106947.USD","LU0823411888.USD","IE0009354923.USD","LU2125154935.USD","LU0882574055.USD","LU1003077747.HKD","LU1244550221.USD","LU0345781412.USD","LU0456855351.SGD","LU2125154778.USD","LU1066051811.HKD","LU0630314457.HKD","LU2362541513.USD","LU0238689110.USD","LU1066051225.USD","LU2168563687.JPY","LU1868836591.USD","SG9999018865.SGD","LU2361045086.USD","LU2023250843.SGD","IE0004445239.USD","LU1699723380.USD","LU2054465674.USD","LU2237443978.SGD","LU1670627923.USD","LU2087621335.USD","LU2265009873.SGD","LU0965509010.AUD","LU0070302665.USD","IE00BDGV0183.EUR","BK4204","IE00B1XK9C88.USD","BK4093","LU1035773651.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU1941712264.USD","LU2271345857.HKD","LU0724618789.USD","LU1059921491.USD","LU0158827781.USD","LU1084165304.USD","LU0237698245.USD","IE00BZ1G4Q59.USD","IE00BYXW3230.USD","IE00BDRTCR15.USD","LU1582987324.SGD","LU1093756168.USD","LU1629891620.HKD","LU0316494557.USD","LU1280957306.USD","LU0106261372.USD","BK4504","IE00B2Q91V27.USD","LU0306806265.USD","LU1989773731.SGD","LU0079474960.USD","LU0149725797.USD","IE00BGHQF631.EUR","LU1670711123.USD","LU2089284900.SGD","LU2023251221.USD","IE00BJJMRX11.SGD","LU0310799852.SGD","LU0068578508.USD","LU1169590202.USD","IE0004445015.USD","LU0106831901.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999015358.SGD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU2089279066.USD","LU1868836757.USD","LU2237443895.HKD","LU2756315318.SGD","LU2430703251.USD","IE00B894F039.SGD","LU0320765992.SGD","LU0787776722.HKD","IE00BJTD4N35.SGD","LU0124676726.USD","LU2430703095.HKD","LU2491050071.SGD","LU0158827948.USD","IE00BGHQF524.EUR","LU2129689514.USD","IE00B7KXQ091.USD","SG9999015341.SGD","LU2746668461.USD","LU1983299246.USD","LU0689472784.USD","IE0002141913.USD","SGXZ99366536.SGD","BK4196","LU1670628061.USD","LU2456880835.USD","BK4613","LU2087625088.SGD","LU0868494617.USD","BK4017","LU0689626769.HKD","LU1720051108.HKD","LU2129689605.HKD","LU1839511570.USD","LU0965509101.SGD","SG9999003800.SGD","LU2106854487.HKD","LU0109391861.USD","LU1037948541.HKD","BK4533","LU2505996681.GBP","LU1196500208.SGD","LU0889565916.HKD","LU1169589451.USD","LU2236285917.USD","LU2242646821.SGD","LU1929549753.HKD","LU0048584097.USD","LU2362541273.HKD","SG9999014898.SGD","LU0965509283.SGD","LU1989771016.USD","LU2324357040.USD","LU1069347547.HKD","LU2168564222.USD","LU2471134523.USD","LU0265550946.USD","BK4007","LU1223082519.USD","LU0964807845.USD","LU1162221912.USD","LU1582986433.USD","SG9999011175.SGD","LU1267930573.SGD","IE00B2B36J28.USD","LU0788109394.HKD","LU0211328371.USD","BK4566","LU2129689431.USD","LU0795875086.SGD","LU1221951046.USD","LU2498475776.HKD","LU0417517546.SGD","LU1989772840.SGD","LU1291159041.SGD","LU1935042991.SGD"],"gpt_icon":1},{"id":"2590311199","title":"美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311199","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590311199?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 17:27","pubTimestamp":1765272424,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4585","BK4007","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0070302665.USD","BK4588","01477","LU0211331839.USD","BK1574","LU0208291251.USD","IE0009355771.USD","NVS","BK4532","BK4578","BK1191"],"gpt_icon":0},{"id":"2590390096","title":"诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590390096","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590390096?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 15:03","pubTimestamp":1765263792,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药将支付英国生物技术公司 Relation Therapeutics Ltd. 高达 17 亿美元，以帮助寻找治疗过敏性疾病的药物靶点。今年早些时候，诺华制药同意以 14 亿美元收购 Tourmaline Bio 公司，从而获得一种有望减轻全身性炎症的治疗方法。该公司还同意以最高 17 亿美元的价格收购美国生物技术公司 Regulus Therapeutics，并通过收购美国生物技术公司 Anthos Therapeutics 进一步丰富其心脏病学产品组合，以获得一种预防中风的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0211331839.USD","01477","NVS","IE00BJJMRZ35.SGD","BK4532","BK4578","IE0009355771.USD","BK1574","LU0070302665.USD","IE0002141913.USD","BK4585","BK4007","BK4588","LU0208291251.USD","BK1191","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2590451393","title":"吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451393","media":"Minhua笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590451393?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 11:58","pubTimestamp":1765166299,"startTime":"0","endTime":"0","summary":"在ASH 2025年会上，吉利德旗下Kite Pharma公布Anito-cel在iMMagine-1 II期试验中的更新数据，该靶向BCMA的CAR-T疗法在复发/难治性多发性骨髓瘤患者中显示96% ORR、74% sCR/CR率、95% MRD阴性率，中位随访15.9个月，缓解持续。III期iMMagine-3试验正在招募中，该研究将Anito-cel与标准治疗比较，预计2026年获得数据；该药物获FDA快速通道、孤儿药和RMAT资格。ICANS 发生率为 8%，其中 1 例为 3 级；其余均为 2 级或更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823416689.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1839511570.USD","IE00B19Z3581.USD","BK4585","SG9999015945.SGD","PFS","IE0002270589.USD","IE00B66KJ199.SGD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","GILD","LU0109394709.USD","CRS","BK4588","BK4139","IE00B7SZL793.SGD","LU1066051498.USD","LU1778281490.HKD","ORR","BK4097","LU1674673428.USD","BK4187","BK4568","LU1585245621.USD","LU1571399168.USD","SG9999015978.USD","BK4109","LU1674673691.USD","BK4532","BK4550","SG9999015952.SGD","BK4578","BK4566","LU0320765992.SGD","LU0889565916.HKD","IE00B19Z4B17.USD","LU1430594728.SGD","IE00BKVL7J92.USD","OS","LU0882574055.USD","BK4195","CR","ASH","KOL","SG9999015986.USD","LU0234570918.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}